Home
Scholarly Works
W Docetaxel plus prednisone or mitoxantrone plus...
Conference

W Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: Updated survival of the TAX 327 study

Authors

Berthold DR; Pond G; DeWit R; Eisenberger M; Tannock IF

Volume

25

Publisher

AMER SOC CLINICAL ONCOLOGY

Publication Date

June 20, 2007

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

18

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team